TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 2 (TAB2) (C-Term) Peptide
TAB2
Reactivity: Human
BP
Sodium azide
-
- Target See all TAB2 products
- TAB2 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 2 (TAB2))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
14 amino acid peptide near the carboxy terminus of human TAB2.
Human
-
-
- Application Notes
- TAB2 peptide is used for blocking the activity of TAB2.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- TAB2 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 2 (TAB2))
- Synonyms
- CHTD2 Peptide, MAP3K7IP2 Peptide, 1110030N06Rik Peptide, A530078N03Rik Peptide, Map3k7ip2 Peptide, mKIAA0733 Peptide, map3k7ip2 Peptide, zgc:77446 Peptide, TGF-beta activated kinase 1/MAP3K7 binding protein 2 Peptide, TAB2 Peptide, Tab2 Peptide, tab2 Peptide
-
You are here:
